Yayın:
Design and synthesis of thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen as potential MetAP (type II) inhibitors

dc.contributor.authorYilmaz, Ozgur
dc.contributor.authorBiliz, Yagmur
dc.contributor.authorAyan, Sumeyra
dc.contributor.authorCevik, Ozge
dc.contributor.authorKarahasanoglu, Mufide
dc.contributor.authorCotuker, Reyhan
dc.contributor.authorSahin, Naz Mina Mert
dc.contributor.authorGokkaya, Kubra
dc.contributor.authorGulyuz, Sevgi
dc.contributor.authorYelekci, Kemal
dc.contributor.authorKucukguzel, S. . Guniz
dc.date.accessioned2026-06-27T15:15:12Z
dc.date.issued2025
dc.description.abstractIn the present study, a range of novel thiosemicarbazides 4a-i and 1,2,4-triazoles 5a-i derived from ibuprofen, were synthesized. Structural elucidation of these synthesized compounds was performed utilizing a variety of spectroscopic methods, including FTIR, 1H NMR, 13C NMR and HR-MS. The synthesized compounds were tested for cytotoxicity in five different cancer cell lines (cervical cancer (HeLa), human breast cancer (MCF-7), human gastric adenocarcinoma (MKN-45), human metastatic prostate cancer (PC3) and human glioblastoma (U87)). The compounds were compared with healthy cells (NIH-3T3) and the most effective compounds were determined by means of the selectivity index. Thiosemicarbazides derived form ibuprofen 4i and 4d showed anticancer activity, while 1,2,4-triazoles derived form ibuprofen 5b, 5c, 5d, 5e, 5h, 5g showed anticancer activity in HeLa, MCF-7, MKN-45, PC3 and U87 cells. To test the stability of the protein-drug complexes all 18 compounds 4a-i and 5a-i were docked into the active site of the MetAP2 enzyme In general, computational inhibition constants values were correlated with the experimental values. The dynamic behavior of MetAP2-inhibitor complexes was analyzed using all atoms Molecular Dynamic (MD) simulations for 200 ns duration. MD revealed that the drugs bind in the active center of MetAP2 with stable RMSD and RMSF. In conclusion, in-silico results and in-vitro studies suggests that thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen may be novel anticancer drug candidates for treating cervical, breast, prostate, gastric and glioblastoma. Compounds provided induction of apoptotic proteins in the cell by inhibiting MetAP2 enzyme. Furthermore, the potential antioxidant activities of the compounds were evaluated using the 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity assay. Among the compounds tested, 4a, 4b, 4e, 4f, 4h, and 4i exhibited values closely resembling the DPPH activity of the standards.en
dc.description.sponsorshipTurkish Health Institutes Presidency (TUSEB) [4235]
dc.description.urihttps://doi.org/10.1016/j.cbi.2025.111555
dc.identifier.doi10.1016/j.cbi.2025.111555
dc.identifier.eissn1872-7786
dc.identifier.issn0009-2797
dc.identifier.pubmed40345475
dc.identifier.urihttps://hdl.handle.net/20.500.14981/69518
dc.identifier.volume416
dc.identifier.wos001492248400001
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofCHEMICO-BIOLOGICAL INTERACTIONS
dc.subjectThiosemicarbazide
dc.subject4-triazole
dc.subjectIbuprofen
dc.subjectCytotoxicity
dc.subjectMetAP2
dc.subjectAntioxidant
dc.subjectMolecular modeling
dc.subjectANTIOXIDANT ACTIVITIES
dc.subjectCOLON-CANCER
dc.subjectDERIVATIVES
dc.subjectDRUG
dc.subjectBiochemistry & Molecular Biology
dc.subjectPharmacology & Pharmacy
dc.subjectToxicology
dc.titleDesign and synthesis of thiosemicarbazides and 1,2,4-triazoles derived from ibuprofen as potential MetAP (type II) inhibitors
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar